Topical application of WR-2721 achieves high concentrations in the rectal wall. 1995

E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
Department of Radiation Oncology, Wayne State University, Detroit, Michigan 48201, USA.

Rectal wall injury is an important treatment-related morbidity in patients treated with radiation for prostate cancer. We have undertaken this study to investigate the merits of topical intrarectal application of the radioprotective compound WR-2721. Male Copenhagen rats were injected intrarectally with 2% WR-2721 gel. At 10, 20, 30 and 40 min after application, a laparotomy was performed, and the rectum and prostate were removed. Concentrations of total WR-1065 (the active metabolite of WR-2721) were determined in these samples by an HPLC assay. While the concentration in the rectal wall tended to increase with time, it did not change substantially in the prostate. The concentration in the rectal wall was found to be significantly higher at all times. We conclude that preferential accumulation of WR-2721 in the rectal wall can be achieved by topical application. This is a promising approach to modifying rectal wall tolerance that deserves more study.

UI MeSH Term Description Entries
D008297 Male Males
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004999 Amifostine A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia. Ethiofos,Gammaphos,APAETP,Amifostine Anhydrous,Amifostine Disodium Salt,Amifostine Monohydrate,Amifostine Monohydrochloride,Amifostine Trihydrate,Aminopropyl Aminoethylthiophosphate,Aminopropylaminoethylthiophosphate,Aminopropylaminoethylthiophosphoric Acid,Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), trihydrate,Ethiofos Anhydrous,Ethyol,NSC-296961,S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid,WR-2721,YM-08310,NSC 296961,NSC296961,WR 2721,WR2721,YM 08310,YM08310
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
October 1994, Cancer,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
June 1992, Cancer,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
January 1988, Pharmacology & therapeutics,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
June 1992, Cancer,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
June 1985, International journal of radiation oncology, biology, physics,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
August 1986, International journal of radiation oncology, biology, physics,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
January 1988, Pharmacology & therapeutics,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
January 1988, Pharmacology & therapeutics,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
January 1987, Acta physiologica et pharmacologica Bulgarica,
E Ben-Josef, and J Mesina, and L M Shaw, and H S Bonner, and F Shamsa, and A T Porter
September 1984, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!